KDS.AS Gross Margin

The Gross Margin of Kiadis Pharma NV (KDS.AS) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

KDS.AS Gross Margin - Peers Comparison

Ticker	Name	Value
CANTA.ST	Cantargia AB	7775.20%
SANION.ST	Saniona AB	85.03%
EGTX.ST	Egetis Therapeutics AB (publ)	74.84%
HPHA.DE	Heidelberg Pharma AG	74.01%
MDXH.BR	MDxHealth SA	51.74%
ALBPS.PA	Biophytis SA	7775.20%
ARGX.BR	argenx SE	89.63%
ETX.L	E-Therapeutics PLC	100.00%
MAB.WA	Mabion SA	75.54%
PHARM.AS	Pharming Group NV	88.09%
ALSEN.PA	Sensorion SA	7775.20%
BVXP.L	Bioventix PLC	93.20%
DMYD B.ST	Diamyd Medical AB	-10161.54%
ORPHA.CO	Orphazyme A/S	7775.20%
ORY.MC	Oryzon Genomics SA	-4700.00%
OSE.PA	OSE Immunotherapeutics SA	100.00%
QURE	Uniqure NV	32.42%
VVY.AS	Vivoryon Therapeutics NV	85.50%
BINV.ST	BioInvent International AB	42.37%
POXEL.PA	Poxel SA	0.05%
XBRANE.ST	Xbrane Biopharma AB	90.83%
NANOV.OL	Nordic Nanovector ASA	7775.20%
SCLP.L	Scancell Holdings PLC	90.13%
VSC.DE	4Sc AG	97.20%
ABVX.PA	Abivax SA	-19700.00%
ESP.AS	Esperite NV	65.83%
FARN.L	Faron Pharmaceuticals Oy	95.19%
MRUS	Merus NV	7775.20%
ALQGC.PA	Quantum Genomics SA	-14205.07%
BGBIO.OL	Bergenbio ASA	100.00%
PRQR	ProQR Therapeutics NV	7775.20%
SIGHT.PA	Gensight Biologics SA	188.37%
TILS.L	Tiziana Life Sciences PLC	63.16%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%